Option Care Health, Inc. to Post FY2024 Earnings of $1.19 Per Share, William Blair Forecasts (NASDAQ:OPCH)

Option Care Health, Inc. (NASDAQ:OPCH) – Analysts at William Blair raised their FY2024 EPS estimates for shares of Option Care Health in a research report issued to clients and investors on Wednesday, April 24th. William Blair analyst M. Larew now forecasts that the company will post earnings of $1.19 per share for the year, up from their prior estimate of $1.17. The consensus estimate for Option Care Health’s current full-year earnings is $1.13 per share. William Blair also issued estimates for Option Care Health’s Q1 2025 earnings at $0.30 EPS, Q2 2025 earnings at $0.35 EPS, Q4 2025 earnings at $0.41 EPS and FY2025 earnings at $1.43 EPS.

OPCH has been the topic of several other research reports. Barrington Research reaffirmed an “outperform” rating and issued a $38.00 price target on shares of Option Care Health in a report on Wednesday. Jefferies Financial Group upped their price target on shares of Option Care Health from $36.00 to $38.00 and gave the stock a “buy” rating in a report on Monday, March 4th.

Option Care Health Trading Down 2.2 %

NASDAQ:OPCH opened at $29.93 on Thursday. The firm’s 50 day moving average is $32.13 and its 200 day moving average is $31.52. The company has a current ratio of 1.77, a quick ratio of 1.33 and a debt-to-equity ratio of 0.74. Option Care Health has a 12 month low of $24.23 and a 12 month high of $35.74. The stock has a market capitalization of $5.20 billion, a PE ratio of 19.69, a price-to-earnings-growth ratio of 1.74 and a beta of 1.22.

Option Care Health (NASDAQ:OPCH) last posted its quarterly earnings results on Tuesday, April 23rd. The company reported $0.26 EPS for the quarter, topping analysts’ consensus estimates of $0.22 by $0.04. The company had revenue of $1.15 billion for the quarter, compared to analysts’ expectations of $1.10 billion. Option Care Health had a net margin of 6.15% and a return on equity of 18.92%. Option Care Health’s revenue was up 12.8% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.21 EPS.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of the business. Principal Securities Inc. bought a new stake in shares of Option Care Health in the 4th quarter worth about $27,000. Parallel Advisors LLC increased its stake in Option Care Health by 130.2% during the 4th quarter. Parallel Advisors LLC now owns 845 shares of the company’s stock valued at $28,000 after purchasing an additional 478 shares in the last quarter. TFO Wealth Partners LLC increased its stake in Option Care Health by 24,625.0% during the 4th quarter. TFO Wealth Partners LLC now owns 989 shares of the company’s stock valued at $33,000 after purchasing an additional 985 shares in the last quarter. First Horizon Advisors Inc. acquired a new position in Option Care Health during the 3rd quarter valued at approximately $37,000. Finally, Park Place Capital Corp increased its stake in Option Care Health by 48.4% during the 1st quarter. Park Place Capital Corp now owns 1,140 shares of the company’s stock valued at $38,000 after purchasing an additional 372 shares in the last quarter. Hedge funds and other institutional investors own 98.05% of the company’s stock.

Insiders Place Their Bets

In related news, Director Harry M. Jansen Kraemer, Jr. bought 35,000 shares of the business’s stock in a transaction on Monday, February 26th. The stock was acquired at an average price of $31.55 per share, with a total value of $1,104,250.00. Following the transaction, the director now owns 269,528 shares in the company, valued at approximately $8,503,608.40. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. 0.64% of the stock is currently owned by insiders.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.